Results 151 to 160 of about 2,684,188 (268)

Author Correction: Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes

Scientific Reports
Yinglei Liu, Yamin Zhao, Siming Zhang, Shen Rong, Songnian He, Liqi Hua, Xingdan Wang, Hongjian Chen   +7 more
doaj   +1 more source

Consensus on Human Epidermal Growth Factor Receptor 2 Overexpression Testing in Pan-Tumor. [PDF]

Cancer Innov
Wang Z, Chen L, Rao W, Cao B, Cai M, Fan X, Ji Y, Li Y, Song Y, Sun Y, Sun Y, Wu C, Xia Q, Xi Y, Xue L, Yin R, Liang H, Ying J.   +17 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Profiling the tumor-resident microbiota in small cell lung cancer and its influence on clinical outcomes. [PDF]

J Transl Med
Zhang W, Zhao W, Ye L, Wang H, Chen Z, Liu X, Li Y, Zhang Q, Zhang H, Liu Y, Chen X, Chen S, Zeng J, Huang R, Li Y, He Y.   +15 more
europepmc   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

MCT4 deficiency suppresses tumor incidence and metastasis by downregulating IGF1 expression and enhancing anti-tumor immunity. [PDF]

Commun Biol
Wang S, Guo H, Feng L, Wang X, Zhang Y, Li X, Zhou X, Ma N.   +7 more
europepmc   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Systemic iron availability differentially shapes tumor and brain iron handling in a sex-dependent manner in glioblastoma. [PDF]

PLoS One
Tufano E, Palsa K, Serpa RO, Helmuth TB, Remit-Berthet G, Mills-Huffnagle S, Kant M, Sahu A, Connor JR.   +8 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

A Pan-Cancer Atlas of TIPE2 Identifies Its Association With the Tumor Immune Microenvironment, Prognosis, and Immunotherapeutic Potential. [PDF]

Hum Mutat
Cao H, Jia W, Yang H, Zhang Y, Cao S, Zhou Y, Li Z.   +6 more
europepmc   +1 more source